Tuesday, June 6, 2017
- 1:45pm-3:15pm
-
Three-year follow-up of high-dose ubiquinol supplementation in a case of familial multiple system atrophy with compound heterozygous COQ2 mutations
Therapy in Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Topography of essential tremor
Tremor · Exhibit Hall C
- 1:45pm-3:15pm
-
Transcranial sonography in the prognosis of drug-induced parkinsonism
Drug-Induced Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Treadmill training, Tai Chi, dance and more: a meta-analysis on the effectiveness of different physiotherapy modalities in Parkinson’s disease
Therapy in Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Treatable Rare Movement Disorders
Rare Genetic and Metabolic Diseases · Exhibit Hall C
- 1:45pm-3:15pm
-
Treatment of secondary movement disorders related to midbrain cavernomas
Therapy in Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Tremor Characteristics in Essential Tremor and Dystonic Tremor
Tremor · Exhibit Hall C
- 1:45pm-3:15pm
-
Tremor in motorneuron disease: central or peripheral origin?
Tremor · Exhibit Hall C
- 1:45pm-3:15pm
-
Ultrasonography-guided Botulinum Toxin Type-A Injection in Tremor. An open-label Study
Tremor · Exhibit Hall C